Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR)

CUSIP: 92915B106

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class
Equity / Common Stock, $0.001 par value
Shares outstanding
55,632,823
Total 13F shares
27,690,758
Share change
-379,284
Total reported value
$198,031,668
Put/Call ratio
1324%
Price per share
$7.15
Number of holders
95
Value change
-$6,797,504
Number of buys
40
Number of sells
50

Quarterly Holders Quick Answers

What is CUSIP 92915B106?
CUSIP 92915B106 identifies VYGR - Voyager Therapeutics, Inc. - Common Stock, $0.001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) as of Q4 2020

As of 31 Dec 2020, Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) was held by 95 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 27,690,758 shares. The largest 10 holders included TRV GP III, LLC, ARMISTICE CAPITAL, LLC, Bellevue Group AG, BlackRock Inc., VANGUARD GROUP INC, Clearbridge Investments, LLC, CITADEL ADVISORS LLC, RENAISSANCE TECHNOLOGIES LLC, MORGAN STANLEY, and JPMORGAN CHASE & CO. This page lists 95 institutional shareholders reporting positions in this security for the Q4 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.